Announcements

INTERVIEW: Sativa Group ‘A Big Boost’ from Health Secretary’s Statement
Sativa Group (NEX: SATI) CEO Geremy Thomas joins DirectorsTalk to comment on the statement made by Health Secretary Matt Hancock. Geremy also explains the significance of appointing new broker Cenkos. Sativa is a seed to Consumer…
INTERVIEW: Sativa delighted with Cenkos appointment as it opens CBD wellness centre
Geremy Thomas caught up with Proactive London’s Andrew Scott following the opening of their first cannabidiol (CBD) wellness retail outlet in Bath at the weekend. (Published on 3 Jul 2019) The Goodbody Wellness store was launched…
DJ Sativa Group PLC UK's first prestige CBD wellness chain launched
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Phytovista subsidiary completes largest UK CBD industry blind product test for The Centre for Medicinal Cannabis.
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Exercise of Warrants and Options
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Appointment of Cenkos Securities plc as Corporate Adviser and broker
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Result of Annual General Meeting and Trading Update
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Offtake agreement with Swiss supplier of cannabis oil for the UK manufacture of cannabidiol (CBD) products
Press Release 15th May 2019  The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the…
Offtake agreement with Portuguese supplier of cannabis oil for the UK manufacture of cannabidiol products
Press Release                                                                    …
INTERVIEW: Geremy Thomas, CEO of Sativa Investments shares his views on the European cannabis market... (as featured on Professionally Cannabis)
Professionally Cannabis, met up with Geremy Thomas, CEO of Sativa Investments; Among many topics, they spoke about the companies that sit within the Sativa Group, Geremy’s views on the European cannabis market, and exciting new developments…
Final Results
Press Release                                                                    …
Exercise of Share Options and Total Voting Rights
Press Release                                                                    …
Sativa Strategic Update - 8th May 2019
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Sativa to open first Goodbody & Blunt wellness centre in Bath with lease signed
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Sativa begins cannabinoid research with King’s College London
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Sativa’s PhytoVista Laboratories’ 1000th cannabinoid and terpenes test and two new hires
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Appointment of Director of Regulatory affairs
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Sativa hires retail expert Chris Jones to launch Sativa’s Goodbody & Blunt wellness centres
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Sativa Investments 'at the forefront' of developing UK medical cannabis market
Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London’s Andrew Scott to discuss the NEX-based medical cannabis investor’s trading and strategic update.
Strategic and Trading Update
Press Release 8th January 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the…
Investee business Rapid Dose Therapeutics lists on the Canadian Securities Exchange
Press Release 18 December 2018 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via…
Dr Brown appointed to Advisory Board
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Share Option Scheme
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announces that the Company has adopted the Sativa Investments PLC Share Plan (the “Scheme”), to recognise the work accomplished by the Sativa team
Option agreement on 298,806 sq ft glasshouse signed
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has now signed the option agreement to lease a 7.53 acre site for medicinal cannabis production in Wiltshire on which the Company intends to…
Change in Board responsibilities
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announces that Mark Blower, currently an Executive Director of the Company, is moving to a non-Executive Director role with immediate effect.
Heads of Terms for an option to lease a 7.53 acre UK site for medicinal cannabis production
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has signed Heads of Terms for an £85K option to lease a 7.53 acre development site in Wiltshire.
Sativa Investments Share Placing
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is pleased to announce that it has raised £3.75 million (before expenses) by way of a placing of 62,500,000 new ordinary shares of 0.25p…
Sativa Half Year Financial Results (Unaudited) June 2018
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is pleased to announce its half year results for the six months ended 30 June 2018.
Medicinal cannabis group Sativa enters joint venture with Lexamed GmbH
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has established a joint venture with German-based Lexamed GmbH (“Lexamed”), forming a new German medicinal cannabis company named Sativa Germany GmbH